Passions

Hiking and backpacking

Bay Area professional sports

Poker

Dogs

Admissions and credentials

California

Experience

BioMarin Acquires Inozyme Pharma

May 22, 2025

Cooley advised BioMarin Pharmaceutical (Nasdaq: BMRN), a global biotechnology company dedicated to translating the promise of genetic discovery into medicines that make a profound impact on the life of each patient, on its definitive agreement to acquire Inozyme Pharma for $4 per share in an all-cash transaction valued at approximately $270 million.

Read more

Related contacts

Jamie Leigh
Partner, San Francisco
Ben Beerle
Partner, San Francisco
Siana Lowrey
Of Counsel
Chadwick Mills
Partner, San Francisco
Parth Bhatt
Associate, San Francisco
Alex Hammer
Associate, San Francisco
Talya Kornitzer
Associate, New York
Anne Luquette
Associate, San Francisco
Sangitha Palaniappa
Associate, Palo Alto
Tyler Saavedra-Buckley
Associate, San Francisco
Christine Turner
Associate, Colorado
Megan Browdie
Partner, Washington, DC
Eileen Marshall
Partner, Washington, DC
Christophe Beauduin
Partner, New York
Ross Eberly
Partner, Santa Monica
Natasha Leskovsek
Of Counsel, Washington, DC
Barbara Mirza
Partner, Santa Monica

Related Practices & Industries